Key result
Allplex Respiratory Panel shows good agreement with Anyplex II and FilmArray for detecting respiratory viruses.
Why the study?
The Allplex Respiratory Panel 1/2/3 is a new multiplex PCR assay for detecting respiratory viruses with influenza A subtyping, requiring evaluation against existing assays.
Does the Allplex Respiratory Panel 1/2/3 multiplex PCR assay accurately detect respiratory viruses compared to Anyplex II RV16 in clinical samples?
Observational (n=426)
Does the Allplex Respiratory Panel 1/2/3 multiplex PCR assay accurately detect respiratory viruses compared to Anyplex II RV16 in clinical samples?
The Allplex Respiratory Panel 1/2/3 multiplex PCR assay demonstrates reliable diagnostic performance for detecting respiratory viruses and influenza A subtyping.
Supports Allplex validation in labs; leaves open clinical adoption pending prospective trials versus established assays.
The Allplex Respiratory Panel 1/2/3 (All16) is a multiplex PCR assay for detecting 16 respiratory viruses with influenza A virus (FluA) subtyping, and the first clinical assay based on multiple detection temperatures. We compared the results between All16 and Anyplex II RV16 (Any16) in 426 clinical samples. Samples showing discrepancies between the two tests were further tested using monoplex PCR. FluA subtyping based on the hemagglutinin type results of All16, which yielded H1, H3, and non-H1/H3, was compared with the results of the BioFire FilmArray respiratory panel. The positive and negative percent agreements and kappa value for each virus between All16 and Any16 ranged from 54.5-100.0%, 84.7-100.0%, and 0.57-1.00, respectively. FluA subtype results from All16 for 26 samples were consistent with those from FilmArray. Good agreement was observed between the two methods, except when analyzing human enterovirus (kappa value 0.70), and the All16 showed reliable FluA subtyping results. For parainfluenza virus 3, the All16 was more sensitive than Any16. When testing 28 samples simultaneously, the mean test time and hands-on time were 4.3 and 0.5 hours, respectively in All16. In conclusion, All16 showed reliable performance, but further studies are needed regarding human enterovirus analysis.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2017) conducted an observational in Respiratory virus infection (n=426). Allplex Respiratory Panel 1/2/3 (All16) vs. Anyplex II RV16 (Any16) was evaluated on Positive and negative percent agreements and kappa value (kappa 0.57-1.00). The Allplex Respiratory Panel 1/2/3 showed good agreement with Anyplex II RV16 for detecting respiratory viruses (kappa 0.57-1.00), with reliable Influenza A subtyping compared to FilmArray.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: